Introduction to MLPA Spinal Muscular Atrophy SMA SMN 1&2 Test

The MLPA SMA SMN 1 & 2 Test is a genetic test for diagnosing Spinal Muscular Atrophy (SMA), which is a neuromuscular disorder that results in muscle weakness and wasting. The test analyzes the SMN 1 and SMN 2 genes, which are crucial for muscle function. 

Early diagnosis enables access to appropriate treatments and support services. Understanding the genetic basis of SMA helps research and develop new therapies. However, people with symptoms of SMA, such as muscle weakness, difficulty swallowing, or breathing problems, should consider this test. 

People must benefit from SMA through carrier testing to assess their risk of passing on the gene. Pregnant women with a family history of SMA might opt for prenatal testing. 

If you have any doubts or questions related to your test, you should consult a healthcare professional and take the MLPA Spinal Muscular Atrophy SMA SMN 1&2 Test from Redcliffe Labs. The professionals here provide the best diagnostic experience, guaranteeing 100% report correctness. 

Test details in brief MLPA Spinal Muscular Atrophy SMA SMN 1&2 Test

What is the purpose of the MLPA Spinal Muscular Atrophy SMA SMN 1&2 Test? 

The MLPA Spinal Muscular Atrophy SMN1 & SMN2 test is used to diagnose Spinal Muscular Atrophy, a genetic disorder characterized by motor neuron loss that leads to muscle weakness and atrophy. 

The test focuses on the following-

• Diagnosis- To confirm a diagnosis of SMA in individuals showing symptoms of muscle weakness and atrophy.
• Carrier Testing- To identify carriers of the SMA gene who may be at risk of passing the condition to their children.
• Prenatal Testing- It is helpful to determine if a fetus is affected by SMA, if there is a family history of the disorder, or if both parents are known carriers.
• SMN2 Copy Number Analysis—This is to assess the number of SMN2 gene copies that can influence the severity of the disease. 

Preparation for the MLPA Spinal Muscular Atrophy SMA SMN 1&2 Test

There is no special preparation required for the test; here is what you need to follow the instructions-

• Consult with your doctor- If you have any questions, discuss them with your doctors before the test.
• Fasting- It is a genetic test that does not require any special preparation before the test.
• Inform your doctor- If you take any medications or supplements out of any medicines, then inform your doctor.

These steps ensure you are well-prepared for the MLPA SMA SMN1 & SMN2 test, enabling accurate results and appropriate follow-up care.

The procedure of the MLPA Spinal Muscular Atrophy SMA SMN 1&2 Test 

Here is the detailed procedure of the MLPA Spinal Muscular Atrophy SMA SMN 1&2 Test- 

The healthcare expert will tie a tourniquet on the upper arm area to make the vein more visible.

• The patient will be seated comfortably, and a tourniquet (elastic band) will be placed around upper arm to fill the veins with blood.
• He will then clean the puncture site with an antiseptic solution.
• Next, using a sterile needle, he will collect the blood in a vial of tube.
• Once the blood is collected, the needle gets removed, and puncture site is then covered with a cotton ball or bandage to stop any bleeding.
• The tube is labeled with the patient’s details and sent to a laboratory for analysis.

What do the MLPA Spinal Muscular Atrophy SMA SMN 1&2 Test reports show?

The MLPA Spinal Muscular Atrophy (SMA) SMN 1&2 Test reports provide detailed information about the genetic status of the SMN1 and SMN2 genes. These reports can indicate the following:

SMN1 Gene Deletion or Mutation- 

• Presence of SMN1 Gene Deletion—The report will indicate whether one or both copies of the SMN1 gene have been deleted.
• Carrier Status- If there is a deletion in only one copy of the SMN1 gene, the person is a carrier of SMA.

SMN2 Gene Copy Number

• Number of SMN2 Copies- The report will detail the number of SMN2 gene copies present. The SMN2 gene compensates for the loss of SMN1 function. A higher number of SMN2 copies is associated with a milder phenotype of SMA. 

The report provides information about the genetic alterations in the SMN1 and SMN2 genes, including deletions, duplications, or other mutations identified during the test.

Who should take the MLPA Spinal Muscular Atrophy SMA SMN 1&2 Test?

Here is who is recommended for the MLPA Spinal Muscular Atrophy SMA SMN 1 & 2 Test:

• People with a Family History
• Prospective Parents
• Prenatal Testing
• People with Symptoms of SMA
• Newborn Screening

What are the common symptoms of MLPA Spinal Muscular Atrophy SMA SMN 1&2?

Spinal Muscular Atrophy (SMA) is a genetic disorder ususally caused due to loss of motor neurons in the spinal cord and brainstem and may lead to muscle weakness and atrophy. Here are common symptoms related to SMA types-

• Severe muscle weakness
• Poor muscle tone
• Lack of motor development
• Breathing difficulties
• CCSwallowing and feeding difficulties
• Weak cry and cough
• Respiratory issues
• Tremors

What is the MLPA Spinal Muscular Atrophy SMA SMN 1&2 Test price at Redcliffe Labs?

The SMA SMN 1 & 2 test price at Redcliffe Labs is ₹6700. Our Labs follow the highest quality standards as per NABL & ISO guidelines. We have 50+ internal & external quality control checks regularly. The professionals follow Six Sigma Processes, ensuring 100% Report correctness. Moreover, we are trusted by more than 50,000 Doctors across India. We also offer value benefits worth INR 999/- that are passed on to the consumers, which include personalized diet plans, health progress reports, and report consultations. So, if you are looking for any diagnostic test, book your health checkup with Redcliffe Labs.

MLPA- Spinal Muscular Atrophy (SMA)- SMN 1&2 Test Cost in Different Cities - Redcliffe Labs

Note: We also offer MLPA- Spinal Muscular Atrophy (SMA)- SMN 1&2 Test PAN India. Please call the number 8988988787 to check the availability of our services in your area.